id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-008837-74rfnt1x	Tsang, Kenneth WT	H5N1 influenza pandemic: contingency plans	2005-08-11		.txt	text/plain	1045	78	50	12 The two neuraminidase inhibitors, oseltamivir and zanamivir, have not been directly compared in controlled trials. 15, 16 Therefore governments should also consider stockpiling zanamivir as an anti-influenza agent in their pandemic plans. Governments and health agencies should also consider planning for clinical trials, for instance a combination of both neuraminidase inhibitors, with or without other potential novel drugs, such as shortinterfering RNAs and interferon. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance Efficacy and safety of inhaled zanamivir for the treatment of influenza in patients with asthma or chronic obstructive pulmonary disease: a double-blind, randomized, placebocontrolled multicentre study	./cache/cord-008837-74rfnt1x.txt	./txt/cord-008837-74rfnt1x.txt